Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663792 · ClinicalTrials.gov registry record · NA
Dietary Seaweed and Early Breast Cancer: A Randomized Trial
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01663792 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 15 participants.
The verdict
NCT01663792, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Could daily consumption of seaweed help explain lower postmenopausal breast cancer (BC) incidence and mortality rates in Japan? This small proof of principle clinical trial was designed to test the idea that the same amount of seaweed normally eaten in Japan would induce metabolic changes when given to non-seaweed consuming healthy postmenopausal American women. The participants were given 10 capsules a day (about 1 tablespoon) for 3 months. During the first month the capsules contained placebo, the second month seaweed, and the third month placebo. We collected blood and urine samples after each treatment period and tested for changes in protein expression that might be related to consuming seaweed.
Interventions
- OTHER Placebo
- OTHER Seaweed
- OTHER Placebo2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01663792
The ClinicalTrials.gov registry entry for NCT01663792 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01663792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01663792 about?
NCT01663792 is a clinical study titled "Dietary Seaweed and Early Breast Cancer: A Randomized Trial". Could daily consumption of seaweed help explain lower postmenopausal breast cancer (BC) incidence and mortality rates in Japan? This small proof of principle clinical trial was designed to test the idea that the same amount of seaweed normally eaten in Japan would induce metabolic changes when given...
What is the current status of trial NCT01663792?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2006-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT01663792?
The interventions under investigation include: Placebo (OTHER), Seaweed (OTHER), Placebo2 (OTHER).
Who is sponsoring clinical trial NCT01663792?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.